Streetbeat News

Revenues

RVER

SNAP

SOCL

Snap Inc (NYSE:SNAP) is investing in AI and machine learning to enhance Snapchat, aiming to make the app more engaging. CEO Evan Spiegel has organized senior machine learning experts to strategize on achieving state-of-the-art advancements. This follows years of revamping Snapchat’s advertising business, which is now showing positive results. Snap reported quarterly sales of $1.195 billion, up 21% year-on-year, and quarterly earnings of $0.03, beating analyst estimates. Snap stock gained 66% in the last 12 months. Investors can gain exposure to the stock via Global X Social Media ETF (NASDAQ:SOCL) and Advisor Managed Portfolios Trenchless Fund ETF (NYSE:RVER).

Portfolio Pulse from Anusuya Lahiri

May 20, 2024 | 4:18 pm

WMT

The options market shows a bullish stance on Walmart (NYSE:WMT) with 26 call trades totaling $1,713,216 and 2 put trades totaling $125,304. Analysts have mixed ratings with an average price target of $71.4. Walmart's stock is currently at $64.42, down by 0.36%.

Portfolio Pulse from Benzinga Insights

May 20, 2024 | 4:16 pm

CAN

Canaan shares are trading higher following the company's better-than-expected Q1 revenue report, reaffirmed Q2 topline outlook, and issued Q3 revenue guidance.

Portfolio Pulse from Benzinga Newsdesk

May 20, 2024 | 4:13 pm

HIMS

NVO

Hims & Hers Health Inc (NYSE:HIMS) announced the addition of GLP-1 injections to its weight loss portfolio, causing its stock to soar by 34.9%. The company now offers GLP-1 injections and weight management oral medication kits, providing an alternative to Novo Nordisk's (NYSE:NVO) Ozempic and Wegovy. Hims & Hers expects its weight loss program to generate over $100 million in revenue by the end of 2025.

Portfolio Pulse from Vandana Singh

May 20, 2024 | 4:07 pm

PTCT

The European Commission has requested a reevaluation of the negative opinion on PTC Therapeutics' drug Translarna for Duchenne muscular dystrophy, pausing the company's annual revenue guidance. Translarna remains available in Europe, and PTC plans to resubmit its U.S. marketing application in mid-2024.

Portfolio Pulse from Vandana Singh

May 20, 2024 | 4:03 pm

AXON

Axon Enterprise (NASDAQ:AXON) has significantly outperformed the market over the past 5 years, delivering an average annual return of 34.0%. A $100 investment in AXON 5 years ago would be worth $432.76 today. The company's current market capitalization is $21.89 billion.

Portfolio Pulse from Benzinga Insights

May 20, 2024 | 4:00 pm

BE

Bloom Energy (NYSE:BE) has been analyzed by 8 analysts over the past three months, showing a range of perspectives from bullish to bearish. The average 12-month price target has increased by 7.95% to $15.88. Analysts have adjusted their ratings and price targets, reflecting dynamic market conditions and company performance. Despite a decline in revenue growth, Bloom Energy's net margin, ROE, and ROA surpass industry averages, although the company faces challenges with a high debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

May 20, 2024 | 4:00 pm

FCNCA

First Citizens BancShares (NASDAQ:FCNCA) has significantly outperformed the market over the past 15 years, delivering an average annual return of 19.18%. A $1000 investment in FCNCA 15 years ago would be worth $13,903.74 today. The article highlights the power of compounded returns over time.

Portfolio Pulse from Benzinga Insights

May 20, 2024 | 4:00 pm

ACB

CGC

MJ

MSOS

TLRY

Cannabis stocks surged following the U.S. Department of Justice's proposal to reclassify cannabis from a Schedule I to a Schedule III drug. Canopy Growth (NASDAQ:CGC) led the surge, with Tilray Brands (NASDAQ:TLRY) and Aurora Cannabis (NASDAQ:ACB) also seeing gains. Cannabis ETFs like AdvisorShares Pure US Cannabis ETF (NYSE:MSOS) and Amplify Alternative Harvest ETF (NYSE:MJ) experienced increased trading but later pulled back. Emily Paxhia of Poseidon Investment Management discussed the broader implications and challenges ahead.

Portfolio Pulse from Patricio Liddle

May 20, 2024 | 3:58 pm

JPM

JP Morgan CEO Jamie Dimon mentioned potential future organic growth opportunities during the Investor Day event.

Portfolio Pulse from Benzinga Newsdesk

May 20, 2024 | 3:52 pm